Here’s Why You Must Consider Investing in Guardant Health (GH)

view original post

ClearBridge Investments, an investment management firm, published its “Multi-Cap Growth Strategy” third quarter 2021 investor letter – a copy of which can be downloaded here. The ClearBridge Multi Cap Growth Strategy underperformed its Russell 3000 Growth Index benchmark in the third quarter. On an absolute basis, the Strategy generated losses across the six sectors in which it was invested (out of 11 sectors total). You can take a look at the fund’s top 5 holdings to have an idea about their best picks for 2021.

ClearBridge Multi Cap Growth Strategy, in its Q3 2021 investor letter, mentioned Guardant Health, Inc. (NASDAQ: GH) and discussed its stance on the firm. Guardant Health, Inc. is a Redwood City, California-based biotechnology company with a $9.1 billion market capitalization. GH delivered a -9.78% return since the beginning of the year, while its 12-month returns are down by -36.84%. The stock closed at $90.24 per share on January 06, 2022.

Here is what ClearBridge Multi Cap Growth Strategy has to say about Guardant Health, Inc. in its Q3 2021 investor letter:

“Innovation within the health care sector has long been an area of focus in the Strategy and we plan to continue to maintain a meaningful overweight to the sector. That said, we expect this will be reflected in more diversified exposures beyond therapeutics companies. Some of the emerging areas of interest include diagnostics, life science tools, labs and other related services, where we own liquid biopsy leader Guardant Health and are working to build new holdings.”


Based on our calculations, Guardant Health, Inc. (NASDAQ: GH) was not able to clinch a spot in our list of the 30 Most Popular Stocks Among Hedge Funds. GH was in 31 hedge fund portfolios at the end of the third quarter of 2021, compared to 49 funds in the previous quarter. Guardant Health, Inc. (NASDAQ: GH) delivered a -13.51% return in the past 3 months.

In September 2021, we also shared another hedge fund’s views on GH in another article. You can find more than 100 investor letters from hedge funds and prominent investors on our hedge fund investor letters 2021 Q3 page.

Disclosure: None. This article is originally published at Insider Monkey.